Monthly Archives: July, 2024

Browse our exclusive articles!

Tempus AI Inc Receives Buy Rating with $50 Target Price – Oncology Diagnostics Leader Shows Promising Growth Potential

Leading oncology diagnostics company, Tempus AI Inc, receives Buy rating with $50 target price, showing promising growth potential in the field.

Poe Unveils Previews Feature, Luma Labs Innovates AI, Magnific AI Debuts Plugin, Nvidia’s Open-Source Competition, TSMC Valued at $1T, Hebbia Raises $130M, ChatGPT Study...

Discover the latest in AI innovation with OpenAI, Poe, Luma Labs, Magnific AI, Nvidia, TSMC, Hebbia, and ChatGPT in this tech news roundup.

Nvidia Stock Soars, Pfizer Declines: Midyear Investment Report Reveals Surprising Winners and Losers

Discover the midyear investment report revealing winners like Nvidia stock and losers like Pfizer, showcasing diverse results from a ChatGPT portfolio.

3 Undervalued AI Stocks Poised for Breakout

Discover three undervalued AI stocks on the brink of a breakout. C3.ai, Lemonade, and UiPath offer promising growth potential for investors.

C3.ai Emerges as Top AI Stock for 2024

Discover why C3.ai is emerging as the top AI stock for 2024 with innovative solutions and a strong client base. Watch this company in the evolving AI industry.

Popular

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.

Pioneering Research Uncovers Vital Biomarker for Orbital Inflammation

An in-depth study reveals HLF as a potential biomarker for orbital inflammation, offering new insights for diagnosis and treatment strategies.

Subscribe

spot_imgspot_img